BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20732965)

  • 1. High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Zhu S; Bruggeman R; Zaino RJ; Evans DB; Fleming JB; Gomez HF; Zander DS; Wang H
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2598-604. PubMed ID: 20732965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Peng L; Liang J; Wang H; Song X; Rashid A; Gomez HF; Corley LJ; Abbruzzese JL; Fleming JB; Evans DB; Wang H
    Clin Cancer Res; 2010 Jul; 16(14):3734-42. PubMed ID: 20628027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma.
    Liu Z; Teng XY; Meng XP; Wang BS
    World J Surg Oncol; 2014 Nov; 12():348. PubMed ID: 25407240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma.
    Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y
    World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
    Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
    Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.
    Koshiba T; Hosotani R; Miyamoto Y; Ida J; Tsuji S; Nakajima S; Kawaguchi M; Kobayashi H; Doi R; Hori T; Fujii N; Imamura M
    Clin Cancer Res; 2000 Sep; 6(9):3530-5. PubMed ID: 10999740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma.
    Scaife CL; Shea J; Emerson L; Boucher K; Firpo MA; Beckerle MC; Mulvihill SJ
    HPB (Oxford); 2010 Jun; 12(5):352-8. PubMed ID: 20590912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.
    Cao D; Zhang Q; Wu LS; Salaria SN; Winter JW; Hruban RH; Goggins MS; Abbruzzese JL; Maitra A; Ho L
    Mod Pathol; 2007 May; 20(5):570-8. PubMed ID: 17396143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].
    Liu FF; Wei J; Lang RG; Fan Y; Cui LF; Gu F; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):529-35. PubMed ID: 19094464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Foo WC; Rashid A; Wang H; Katz MH; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2013 Jun; 44(6):1024-30. PubMed ID: 23260327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L
    Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients.
    D'Alterio C; Giardino A; Scognamiglio G; Butturini G; Portella L; Guardascione G; Frigerio I; Montella M; Gobbo S; Martignoni G; Napolitano V; De Vita F; Tatangelo F; Franco R; Scala S
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
    Ann Surg Oncol; 2004 Feb; 11(2):165-72. PubMed ID: 14761919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.
    Wang L; Gu F; Ma N; Zhang L; Bian JM; Cao HY
    Tumour Biol; 2013 Aug; 34(4):2309-13. PubMed ID: 23568706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.
    Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma.
    Mahipal A; Mcdonald MJ; Witkiewicz A; Carr BI
    Med Oncol; 2012 Mar; 29(1):134-9. PubMed ID: 21264542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma.
    Jiang NY; Woda BA; Banner BF; Whalen GF; Dresser KA; Lu D
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1648-52. PubMed ID: 18628415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.